STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Dec. 31, 2024

STOCK-BASED COMPENSATION

Schedule of stock option activity

					Weighted Average
					Remaining		Aggregate
			Weighted Average		Contractual		Intrinsic Value
	Shares		Exercise Price		Life (in years)		(000)'s
Outstanding at July 1, 2024		830,000	$	9.39
Granted		10,000	$	11.77
Exercised		-	$	-
Forfeited		-	$	-
Outstanding at December 31, 2024		840,000	$	9.42		9.39	$	1,765
Vested at period-end		-	$	-
Expected to vest		840,000	$	9.42		9.39	$	1,765

Schedule of stock options granted under the stock plan by exercise price range

		Exercise Price Ranges
		$9.39		$11.77		Total
Outstanding at December 31, 2024
Number of Stock Options Outstanding		830,000		10,000		840,000
Weighted-Average Remaining Contractual Life (in years)		9.38		9.96		9.39
Weighted-Average Exercise Price	$	9.39	$	11.77	$	9.42

Schedule of stock option information

		During the six months ended			During the fiscal year ended
		December 31, 2024			June 30, 2024
Weighted average grant date information
Stock options granted		10,000			830,000
Fair value of options granted	$	4.69		$	3.85
Fair value assumptions:
Expected volatility		30.19	%		31.34	%
Dividend yield		-	%		-	%
Risk free interest rate		4.18	%		4.31	%
Expected lives (in years)		6.50			6.50
Amount expensed during the period (in thousands)	$	320		$	72
Compensation costs for non-vested awards not yet recognized (in thousands)	$	2,851		$	3,124
Weighted average expected vesting period, in years		2.40			2.89
Proceeds from stock options exercised	$	-		$	-
Tax benefits related to stock options exercised	$	-		$	-
Intrinsic value of stock options exercised	$	-		$	-

Schedule of restricted stock activity

		Weighted Average
		Grant Date
	Shares	Fair Value
Non-vested at July 1, 2024	390,000	$	9.39
Granted	5,000		11.77
Vested	-		-
Non-vested at December 31, 2024	395,000		9.42

Schedule of amounts expensed related to share-based payment awards

The following table presents information on the amounts expensed related to restricted stock awarded pursuant to the Stock Plan for the six months ended December 31, 2024.

Amount expensed during the year (in thousands)	$	367
Compensation costs for non-vested awards not yet recognized (in thousands)	$	3,272
Weighted average expected vesting period, in years		2.40